3-((1H-indol-3-yl)methyl)-6-(4-bromophenyl)-[1,2,4]triazolo[4,3-b][1,2,4]triazine

ID: ALA3799231

Chembl Id: CHEMBL3799231

PubChem CID: 57406045

Max Phase: Preclinical

Molecular Formula: C19H13BrN6

Molecular Weight: 405.26

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Brc1ccc(-c2cnc3nnc(Cc4c[nH]c5ccccc45)n3n2)cc1

Standard InChI:  InChI=1S/C19H13BrN6/c20-14-7-5-12(6-8-14)17-11-22-19-24-23-18(26(19)25-17)9-13-10-21-16-4-2-1-3-15(13)16/h1-8,10-11,21H,9H2

Standard InChI Key:  TWNJPOVZLPPMMG-UHFFFAOYSA-N

Associated Targets(Human)

MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Met TPR/MET fusion protein (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 405.26Molecular Weight (Monoisotopic): 404.0385AlogP: 4.02#Rotatable Bonds: 3
Polar Surface Area: 71.76Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.67CX LogP: 3.60CX LogD: 3.60
Aromatic Rings: 5Heavy Atoms: 26QED Weighted: 0.49Np Likeness Score: -1.34

References

1. Zhan Z, Peng X, Liu Q, Chen F, Ji Y, Yao S, Xi Y, Lin Y, Chen T, Xu Y, Ai J, Geng M, Duan W..  (2016)  Discovery of 6-(difluoro(6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b][1,2,4]triazin-3-yl)methyl)quinoline as a highly potent and selective c-Met inhibitor.,  116  [PMID:27061987] [10.1016/j.ejmech.2016.03.076]

Source